CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Photocure ASA Company Snapshot
Photocure ASA operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Photocure ASA with three other companies in this sector in Norway: Vistin Pharma ASA (2015 sales of 218.37 million Norwegian Kroner [US$25.54 million] ), Norda ASA (38.76 million Norwegian Kroner [US$4.53 million] ), and Biotec Pharmacon ASA (53.28 million Norwegian Kroner [US$6.23 million] of which 56% was BetaGlucans).

Sales Analysis. During the year ended December of 2015, sales at Photocure ASA were NOK 134.72 million (US$15.76 million). This is an increase of 4.5% versus 2014, when the company's sales were NOK 128.95 million.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Photocure ASA
  Stock Performance Chart for Photocure ASA
 
  Stock Data: Recent Stock Performance:
  Current Price (1/13/2017): 39.10
(Figures in Norwegian Kroner)
1 Week -6.9%   13 Weeks -16.1%  
4 Weeks 1.0%   52 Weeks 8.6%  
 
Photocure ASA Key Data:
  Ticker: PHO Country: Norway
  Exchanges: OSL Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 134,717,000
(Year Ending Jan 2016).
Employees: 49
  Currency: Norwegian Kroner Market Cap: 842,394,642
  Fiscal Yr Ends: December Shares Outstanding: 21,544,620
  Share Type: Ordinaere Closely Held Shares: 5,666,148
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.